Prescribing in COVID-19 patients: Should we take into account inflammation?

Br J Clin Pharmacol. 2021 Mar;87(3):719-721. doi: 10.1111/bcp.14524. Epub 2020 Aug 20.
No abstract available

Keywords: COVID-19; drug-drug interactions; inflammation; inhibition drug metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antiviral Agents / therapeutic use
  • COVID-19 / complications*
  • COVID-19 Drug Treatment*
  • Drug Prescriptions*
  • Drug Therapy, Combination
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / etiology*

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents